Tuesday Partner Rx: Improve Clinical Workflows and Enhance ACO Guidance August 23, 2022 LANES Health Information Exchange Contact LANES: Brad Hibbard, Chief Strategy Officer brad.hibbard@lanesla.org Visit LANES.org The Aledade Advantage View Aledade's Resources Read More
LAC DPH Information: Understanding CA Child Care and School Immunization Requirements and Medical Exemptions July 19, 2022 This message is intended for primary care physicians as well as other health care professionals in Los Angeles County ... Read More
Tuesday Partner Rx: Automate the Management of Licenses and Certifications While Maximizing Your Practice’s Revenue July 12, 2022 Automate the Management of Medical Licenses and Certifications While Matching up the Proper Education for Your Needs Dr. Ian Madom, ... Read More
LACMA President and President-Elect Statement on Uvalde School Shooting May 25, 2022 Los Angeles - LACMA President Jeffery Lee, MD and President-Elect Omer Deen, MD today released the following statement after 18 ... Read More
CDPH Health Advisory: CDPH Advises Parents and Caregivers Against Making or Feeding Homemade Infant Formula to Infants May 17, 2022 The California Deparment of Public Health (CDPH) issued a health advisory alerting the public to the potential health dangers ... Read More
Sick of waiting on hold with Big Chain Pharmacies? 😨 📞 September 14, 2021 Los Angeles County Medical Association is Proud to Partner with Capsule! Capsule Pharmacy has finally arrived in LA, offering free ... Read More
LACDPH COVID-19 Vaccine Update: Additional mRNA Dose for Immunocompromised Persons & LAC Healthcare Worker Mandate August 16, 2021 Key Messages The CDC recommends an additional mRNA COVID-19 vaccine dose for moderately and severely immunocompromised people after an initial ... Read More
Offer and Automate Clinical Trials with SiteRx July 27, 2021 Los Angeles County Medical Association is Proud to Partner with SiteRx! What is SiteRx? SiteRx was founded with one goal in ... Read More
CDPH Health Alert: Concerns re: the Use of Bamlanivimab Monotherapy in the Setting of SARS-CoV-2 Variants March 22, 2021 Bamlanivimab is an investigational monoclonal antibody product that received emergency use authorization (EUA) from the U.S. Food and Drug ... Read More